-
Featured
Paradigm Change: Patient and Provider Expectations Around Same-day Discharge
Newly modified enhanced recovery after surgery (ERAS) protocol guides same-day discharge of vaginal hysterectomy patients while maintaining quality of patient care.
-
Featured
Evaluating Post-Menopausal Women's Vulvovaginal Symptoms, Mood and Sex Life
These pioneering studies from Massachusetts General Hospital evaluate the efficacy of two common, low-risk treatments for postmenopausal symptoms against a placebo and assess how much postmenopausal women were bothered by vulvovaginal discomfort symptoms, along with their impact on mood and quality of life.
-
Featured
Vaginal Estradiol, Moisturizer No Better Than Placebo for Postmenopausal Vulvovaginal Symptoms
Neither a prescription vaginal estradiol tablet nor an over-the-counter vaginal moisturizer provides additional benefit over dual placebo in reducing postmenopausal vulvovaginal symptoms, according to the first randomized comparison.
-
Recommendations for Conducting Health Equity Morbidity and Mortality Conferences
Allison S. Bryant, MD, MPH, and Erin Bradley, MD, of the Department of Obstetrics and Gynecology at Massachusetts General Hospital, and colleagues from four other academic medical centers, outline 10 recommendations for implementing successful health equity morbidity and mortality conferences.
-
Standardization of Symptom Metrics Across Menstrual Tracking Apps Could Benefit Research and Clinical Care
Shruthi Mahalingaiah, MD, MS, of the Department of Obstetrics & Gynecology, and colleagues reviewed 20 menstrual health apps on the Apple platform and found the number, language and specificity of metrics differed too much to permit harmonized epidemiologic research, but input from clinicians could change that.
-
Inflammatory Vaginitis in Women on Long-Term Rituximab for Autoimmune Disorders
Caroline M. Mitchell, MD, director of the Vulvovaginal Disorders Program in the Department of Obstetrics & Gynecology, and colleagues have described refractory inflammatory vaginitis as a debilitating potential side effect of long-term B-cell depletion with rituximab.
Gynecology Contributors
-
Caroline M. Mitchell, MD
Director, Vulvovaginal Disorders Program, Investigator, Vincent Center for Reproductive Biology , Assistant Professor, Obstetrics, Gynecology & Reproductive Biology
Recent Article
Inflammatory Vaginitis in Women on Long-Term Rituximab for Autoimmune Disorders
-
May M. Wakamatsu, MD
Director, Female Pelvic Medicine & Reconstructive Surgery, Vice Chair, Gynecology
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Milena M. Weinstein, MD
Director of Research, Female Pelvic Medicine and Reconstructive Surgery Fellowship, Co-director, Center for Pelvic Floor Disorders
Recent Article
Digital Therapeutic Device for Pelvic Floor Muscle Training Provides Faster, Better Results Than Conventional Exercises
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.